Lilly Settles On Rolling Submission For Tirzepatide In Obesity

Accelerated process
Lilly hopes the rolling submission process will acclerate tirzepatide's path to the weight-loss market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business